Valuation : Kenvue Inc.

Market Cap 35.32B 30.4B 28.62B 26.08B 48.79B 3,361B 48.99B 339B 131B 1,712B 133B 130B 5,425B P/E 2026 *
19.3x
P/E 2027 * 16.8x
Enterprise Value 42.42B 36.5B 34.37B 31.32B 58.59B 4,036B 58.83B 407B 157B 2,056B 159B 156B 6,515B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.62x
Free-Float
98.88%
Yield 2026 *
4.59%
Yield 2027 * 4.69%
1 day-2.39%
1 week-7.21%
Current month-5.99%
1 month-6.73%
3 months-0.95%
6 months-2.26%
Current year+2.90%
1 week 17.67
Extreme 17.67
19.18
1 month 17.67
Extreme 17.67
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-3.48%-7.21%-5.94%-19.57% 35.32B
-2.02%-3.39%-10.55%-7.83% 338B
-1.59%-3.95%-12.53%+1.61% 137B
-0.43%-2.30%+4.45%+19.04% 70.48B
-1.77%-2.50%-25.87%-22.63% 49.07B
-2.87%-2.35%+11.35%-35.57% 36.79B
-0.87%-5.56%-0.90%+22.81% 20.2B
-2.28%-3.49%-23.73%-38.67% 19.39B
-2.05%-5.77%+2.25%+7.39% 19B
-0.14%-4.55%-29.77%-15.34% 9.34B
Average -1.67%-2.02%-9.12%-8.88% 73.47B
Weighted average by Cap. -1.69%-1.23%-9.18%-6.11%

Financials

2026 *2027 *
Net sales 15.6B 13.42B 12.64B 11.51B 21.54B 1,484B 21.63B 150B 57.88B 756B 58.56B 57.29B 2,395B 15.97B 13.74B 12.94B 11.79B 22.05B 1,519B 22.14B 153B 59.26B 774B 59.95B 58.65B 2,452B
Net income 1.83B 1.57B 1.48B 1.35B 2.53B 174B 2.54B 17.57B 6.79B 88.71B 6.87B 6.72B 281B 2.11B 1.82B 1.71B 1.56B 2.92B 201B 2.93B 20.29B 7.84B 102B 7.93B 7.76B 324B
Net Debt 7.1B 6.11B 5.75B 5.24B 9.8B 675B 9.84B 68.15B 26.34B 344B 26.65B 26.07B 1,090B 6.52B 5.61B 5.28B 4.81B 9.01B 620B 9.04B 62.61B 24.2B 316B 24.48B 23.95B 1,001B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-09 US$17.75 -3.48% 22,519,367
26-09-08 US$18.39 -1.87% 16,220,487
26-09-04 US$18.74 -1.11% 26,856,871
26-09-03 US$18.95 -0.94% 18,570,436
26-09-02 US$19.13 +2.03% 19,692,893
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.39USD
Average target price
19.50USD
Spread / Average Target
+6.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!